Sanofi: brands it owns and its ownership tree
Sanofi (NASDAQ: SNY) is a publicly listed company headquartered in Paris, France that owns 16 consumer brands.[1]
Sanofi is a French pharmaceutical company based in Paris. Its 2025 Form 20-F reports sales of immunology, vaccines, rare disease, neurology and diabetes medicines.
-
brands owned
-
1
categories
-
0
acquisitions recorded
-
0
divestitures recorded
Company facts
- Legal name
- Sanofi
- Type
- publicly listed company · see all publicly listed company owners
- Headquarters
- 🇫🇷 Paris, France
- Tickers
- NASDAQ: SNY
- SEC CIK
- 0001121404
- Last verified
- · 2 sources
Sanofi in numbers
- Sanofi owns 16 consumer brands tracked here across 1 top-level categories; the largest is healthcare & pharma with 16 brands.[1]
Everything Sanofi owns
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Full-screen interactive tree → · Download as infographic
Brand portfolio by category
Recent changes to this record
Sanofi in the global legal-entity registry
The Global Legal Entity Identifier Foundation (GLEIF) keeps an open register of legal entities. Each entity reports its own parents. We show it as a cross-check on the ownership recorded on this page, which is built from filings.
- Legal entity identifier (LEI)
- 549300E9PC51EN656011
- Registered name
- SANOFI (FR)
- Registration status
- Issued · record updated 17 July 2026
- Parent
- None named: it reports that no person or entity controls it.
- Retrieved
- · GLEIF record (JSON)
Frequently asked questions
What brands does Sanofi own?
Sanofi owns 16 consumer brands tracked here, including Beyfortus, Dupixent, Efluelda, Sarclisa, Vaxigrip and Aprovel.
Is Sanofi a French company?
Yes. Sanofi is headquartered in Paris, France.
Who owns Sanofi?
Sanofi is a publicly listed company owned by its shareholders; it trades as SNY on the NASDAQ.
Sources (2) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Sanofi Annual Report on Form 20-F filed 2026-02-17 — SEC EDGAR, SEC Form 20-F, published 17 February 2026; retrieved 20 October 2026.
- [2] Sanofi Annual Report on Form 20-F filed 2005-04-11 — SEC EDGAR, SEC Form 20-F, published 11 April 2005; retrieved 22 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.